Suppr超能文献

钠、钾、钙及利钠因子在高血压中的作用。

Roles of sodium, potassium, calcium, and natriuretic factors in hypertension.

作者信息

Haddy F J

机构信息

Department of Physiology, Uniformed Services University of the Health Sciences, Bethesda, Md. 20814-4799.

出版信息

Hypertension. 1991 Nov;18(5 Suppl):III179-83. doi: 10.1161/01.hyp.18.5_suppl.iii179.

Abstract

This review first summarizes evidence from animals and humans for and against a role for dietary sodium in the genesis and treatment of hypertension. The evidence for its role is strongest in those subjects with impaired ability to excrete sodium because of organic renal disease or mineralocorticoid excess. Here, restriction of dietary sodium promptly lowers pressure. Its role in the genesis of essential hypertension is more controversial. Nevertheless, it appears that some patients with mild to moderate essential hypertension respond to moderate sodium restriction with a modest fall in pressure. This restriction also seems to reduce the amount of antihypertensive medication needed to keep pressure under control. Next, the mechanism of the pressure response to dietary sodium chloride is considered, with emphasis on potassium depletion and increased plasma levels of prohypertensive sodium pump inhibitor and antihypertensive atrial natriuretic peptide. The evidence for a primary role for dietary potassium in the genesis of hypertension then is summarized; certain subsets of subjects with a high incidence of hypertension also have a lower potassium intake. Some investigators have found that dietary potassium supplementation lowers pressure in established hypertension. This may result from natriuresis and from vasodilation subsequent to stimulation of Na+,K(+)-ATPase in vascular smooth muscle and adrenergic nerve terminals. After the role of dietary calcium is discussed, practical aspects of dietary sodium restriction and dietary potassium supplementation in the therapy for established hypertension are considered. The review concludes with comments on their possible roles in the prevention of hypertension.

摘要

本综述首先总结来自动物和人类的证据,以支持或反对膳食钠在高血压发生和治疗中的作用。对于因器质性肾病或盐皮质激素过多而导致排钠能力受损的受试者,膳食钠作用的证据最为确凿。在此类情况下,限制膳食钠可迅速降低血压。其在原发性高血压发生中的作用更具争议性。然而,似乎一些轻度至中度原发性高血压患者对适度限制钠摄入有适度的血压下降反应。这种限制似乎也能减少控制血压所需的抗高血压药物用量。接下来,探讨了对膳食氯化钠的血压反应机制,重点关注钾缺乏以及高血压钠泵抑制剂和抗高血压心房利钠肽血浆水平升高。然后总结了膳食钾在高血压发生中起主要作用的证据;某些高血压发病率高的受试者亚组钾摄入量也较低。一些研究人员发现,补充膳食钾可降低已确诊高血压患者的血压。这可能是由于利钠作用以及血管平滑肌和肾上腺素能神经末梢中钠钾ATP酶受刺激后引起的血管舒张。在讨论了膳食钙的作用后,考虑了在已确诊高血压治疗中限制膳食钠和补充膳食钾的实际问题。综述最后对它们在预防高血压中的可能作用进行了评论。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验